Novartis with Malaria No More’s Power of One campaign provide two million anti-malarial treatments to children in Zambia

Read more

Sun Pharma to acquire Ranbaxy in $4-billion landmark transaction

Read more

IDMA to organise seminar on Managing Risks for Quality Compliance 2014

Read more

BIRAC and CEFIPRA jointly invites proposals on ‘Red Biotechnology upto Pre-Commercialisation Stage’

Read more

Novartis top Japan executives quit over cancer drug scandal

Read more

US FDA finds contaminated drug ingredient at GSK Ireland plant

Read more

Venus gets marketing nod from Venezuela for meropenem

Read more

Glenmark’s NCE GRC 27864 for chronic inflammatory diseases to take part in human trials

Read more

Optel Vision to invest in pharmaceutical manufacturing industries

Read more

Actavis acquires Silom Medical Company

Read more